Jiangsu Nanfang Medical (603880) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jiangsu Nanfang Medical (603880) has a cash flow conversion efficiency ratio of 0.048x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥12.53 Million ≈ $1.83 Million USD) by net assets (CN¥259.57 Million ≈ $37.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603880 equity financing ratio to measure how much of total assets are equity-financed.
Jiangsu Nanfang Medical - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Jiangsu Nanfang Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Jiangsu Nanfang Medical to evaluate the quality of earnings relative to operating cash generation.
Jiangsu Nanfang Medical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Nanfang Medical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
YC Inox Co Ltd
TW:2034
|
0.044x |
|
Tidewater Midstream and Infrastructure Ltd
TO:TWM
|
-0.025x |
|
Changchun Yidong Clutch Co Ltd
SHG:600148
|
0.014x |
|
TigerElec Co. Ltd
KQ:219130
|
0.051x |
|
NOCIL Limited
NSE:NOCIL
|
0.076x |
|
Precious Shipping Public Company Limited
BK:PSL-R
|
0.038x |
|
Jilin Jian Yisheng Pharmaceutical Co Ltd
SHE:002566
|
0.003x |
|
Hefei Jingsong Intelligent Technology Co. Ltd. A
SHG:688251
|
N/A |
Annual Cash Flow Conversion Efficiency for Jiangsu Nanfang Medical (2012–2025)
The table below shows the annual cash flow conversion efficiency of Jiangsu Nanfang Medical from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Jiangsu Nanfang Medical market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥181.17 Million ≈ $26.51 Million |
CN¥47.73 Million ≈ $6.98 Million |
0.263x | +18.34% |
| 2024-12-31 | CN¥284.41 Million ≈ $41.62 Million |
CN¥63.32 Million ≈ $9.27 Million |
0.223x | +580.74% |
| 2023-12-31 | CN¥474.22 Million ≈ $69.39 Million |
CN¥15.51 Million ≈ $2.27 Million |
0.033x | -35.01% |
| 2022-12-31 | CN¥621.48 Million ≈ $90.94 Million |
CN¥31.28 Million ≈ $4.58 Million |
0.050x | +139.12% |
| 2021-12-31 | CN¥654.90 Million ≈ $95.83 Million |
CN¥-84.25 Million ≈ $-12.33 Million |
-0.129x | -158.50% |
| 2020-12-31 | CN¥700.80 Million ≈ $102.55 Million |
CN¥154.12 Million ≈ $22.55 Million |
0.220x | +278.28% |
| 2019-12-31 | CN¥567.52 Million ≈ $83.05 Million |
CN¥32.99 Million ≈ $4.83 Million |
0.058x | -38.28% |
| 2018-12-31 | CN¥560.04 Million ≈ $81.95 Million |
CN¥52.75 Million ≈ $7.72 Million |
0.094x | +2.84% |
| 2017-12-31 | CN¥537.57 Million ≈ $78.66 Million |
CN¥49.24 Million ≈ $7.20 Million |
0.092x | -76.34% |
| 2016-12-31 | CN¥256.69 Million ≈ $37.56 Million |
CN¥99.35 Million ≈ $14.54 Million |
0.387x | -5.01% |
| 2015-12-31 | CN¥222.51 Million ≈ $32.56 Million |
CN¥90.66 Million ≈ $13.27 Million |
0.407x | +16.89% |
| 2014-12-31 | CN¥210.90 Million ≈ $30.86 Million |
CN¥73.52 Million ≈ $10.76 Million |
0.349x | +191.73% |
| 2013-12-31 | CN¥168.57 Million ≈ $24.67 Million |
CN¥20.14 Million ≈ $2.95 Million |
0.119x | -80.93% |
| 2012-12-31 | CN¥121.38 Million ≈ $17.76 Million |
CN¥76.07 Million ≈ $11.13 Million |
0.627x | -- |
About Jiangsu Nanfang Medical
Jiangsu Nanfang Medical Co., Ltd. engages in the research and development, production, and sale of transdermal, medical proof fabrics, adhesive tapes and bandages, sports protection, first-aid kits, and care products in China and internationally. It offers medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical … Read more